.Viridian Rehabs' phase 3 thyroid eye disease (TED) scientific trial has actually attacked its main ...
.Along with a strong performance history for determining diamonds in the rough, Bain Funds Lifespan ...
.The recent choice to merge Genentech's two cancer teams was made for "clinical factors," execs reve...
.Terns Pharmaceuticals' choice to lose its liver condition ambitions may however repay, after the bi...
.Merck & Co.'s long-running attempt to land a blow on tiny cell lung cancer cells (SCLC) has acqu...
.Some clients along with non-small tissue lung cancer cells (NSCLC) have anomalies in a gene referre...
.MBX has actually elaborated strategies to enjoy over $136 million coming from its IPO as the biotec...
.Relay Rehabs has beaten its survival target in a first-in-human breast cancer cells research study,...
.AstraZeneca has utilized artificial intelligence to create an unique biomarker for its own Daiichi ...
.AstraZeneca execs say they are "certainly not worried" that the failing of tozorakimab in a stage 2...